Botanical species · safety record

Musa x

The EFSA Compendium of Botanicals holds 9 constituent measurements and 1 genotoxicity assay for Musa x. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Musa x paradisiaca L.

9Constituent measurements
1Safety records
4Cited sources
0Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Alkaloids3
  • Saponins2
  • Cardiac glycosides1
  • Cyanogenic glycosides1
  • Oxalates1
  • Tannins1

Plant parts

  • Aerial part of plants4
  • Trunk3
  • Leaves2

Preparations

  • Solvent extraction9

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsTrunkSolvent extractionPhytochemical screeningResolve DOI
SaponinsTrunkSolvent extractionPhytochemical screeningResolve DOI
TanninsTrunkSolvent extractionPhytochemical screeningResolve DOI
AlkaloidsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
AlkaloidsAerial part of plantsSolvent extractionPhytochemical screeningNo resolvable identifier
Cardiac glycosidesLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
Cyanogenic glycosidesAerial part of plantsSolvent extraction1.47 Milligram/100 gramColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
OxalatesAerial part of plantsSolvent extraction56.28 Milligram/100 gramColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
SaponinsAerial part of plantsSolvent extractionPhytochemical screeningNo resolvable identifier

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

OutcomeEndpointTestTested organismMetabolic activationSource
PositiveDNA damage and/or repairsingle cell gel/comet assay in mammalian cells for detection of DNA damageHouse mouse (as animal)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Andrade, C. U. B., Perazzo, F. F., Maistro, E. L. Mutagenicity of the Musa paradisiaca (Musaceae) fruit peel extract in mouse peripheral blood cells in vivo. GENETICS AND MOLECULAR RESEARCH, 2008, vol. 7, no. 3, p. 725-732.
  2. Mbagwu, H., Jackson, C., Ekpo, M., Okopedi, E., Anah, V., Ugwu, C. Gastroprotective effects of ethanolic leaf extract of Musa paradisiaca L.(Musaceae) in rats. Journal of chemical and pharmaceutical research, 2011, vol. 3, no. 3, p. 322-327.
  3. Yakubu, Musa T., Nurudeen, Quadri O., Salimon, Saoban S., Yakubu, Monsurat O., Jimoh, Rukayat O., Nafiu, Mikhail O., Akanji, Musbau A., Oladiji, Adenike T., Williams, Felicia E. Antidiarrhoeal Activity of Musa paradisiaca Sap in Wistar Rats. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015. DOI
  4. Akpabio, U.D., Udiong, D.S., Akpakpan, A.E. The physicochemical characteristics of plantain (Musa Paradisiaca) and banana (Musa Sapientum) pseudostem wastes. Advances in Natural and Applied Sciences, 2012, vol. 6, no. 2, p. 167-172.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue